Clinical Trial Update: Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 results for NKTR-102 in metastatic or locally advanced breast cancer are reported, detailing safety and efficacy outcomes from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• NKTR-102

Snippet

Sponsor: Nektar Therapeutics | Conditions: Tumor, Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-07-09